Creatine kinase (CK) BB, a member of the CK gene family, is a predominantly cytosolic CK isoform in the brain and plays a key role in regulation of the ATP level in neural cells. CK BB levels are reduced in brain regions affected by neurodegeneration in Alzheimer's disease (AD), Pick's disease, and Lewy body dementia, and this reduction is not a result of decreased mRNA levels. This study demonstrates that posttranslational modification of CK BB plays a role in the decrease of CK activity in AD brain. The specific CK BB activity and protein carbonyl content were determined in brain extracts of six AD and six age-matched control subjects. CK BB activity per microgram of immunoreactive CK BB protein was lower in AD than in control brain extracts, indicating the presence of inactive CK BB molecules. The analysis of specific protein carbonyl levels in CK BB, performed by two-dimensional fingerprinting of oxidatively modified proteins, identified CK BB as one of the targets of protein oxidation in the AD brain. The increase of protein carbonyl content in CK BB provides evidence that oxidative posttranslational modification of CK BB plays a role in the loss of CK BB activity in AD. Key Words: Two-dimensional electrophoresis-Protein carbonyls-Creatine kinase -Inactivation-Alzheimer's disease. J. Neurochem. 74, 2520Neurochem. 74, -2527Neurochem. 74, (2000.
Alzheimer's disease (AD) is a multifactorial age-related disorder with an obscure etiology. Recent studies suggest that oxidative stress and altered energy metabolism play roles in the pathogenesis of AD (C. D. Smith et al., 1991; Beal, 1995; Markesbery, 1997; Hoyer, 1998; Munch et al., 1998; Behl, 1999) . The ATP formation rate calculated from the cerebral metabolic rates of oxidized glucose and oxygen is reduced in the brains of Ͼ50% of advanced AD patients (Hoyer, 1992) . Increased production of free radicals was reported in the brains of AD patients (Gotz et al., 1994; Zhou et al., 1995) . Oxidative damage of lipids, nucleic acids, and proteins is present in AD brain regions severely affected by pathological alterations . It is conceivable that increased oxidative modification of brain proteins may disturb neuronal functions by decreasing activities of key metabolic enzymes and affecting cellular signaling systems (C. D. Smith et al., 1992; Malorni et al., 1994) . As a result, a self-propagating cascade of neurodegeneration may be initiated. Although accumulating evidence supports increased oxidative modification of proteins in AD, no specific protein target has been identified.
Creatine kinase (CK) BB is a member of the CK gene family and is a predominant cytosolic CK isoform in the brain. CKs (EC 2.7.3.2) are a family of enzymes that catalyze the reversible transfer of a phosphoryl group between ATP and creatine (Bessman and Carpenter, 1985) . The significance of CK for cell adaptation is supported by data that suggest cell responses to dangerous external challenges include mobilization of the creatine phosphate (CrP)/CK system (Struzynska et al., 1997) and increase of CK BB expression (Aksenov et al., 1998) . Activation of the CrP/CK system and changes in CK expression may be an early indicator of oxidative and bioenergetic stress in the cell (Aksenova et al., 1999) . Transgenic mice that overexpress CK BB in the liver (tissue that is known to have low levels of CK activity and extremely low levels of CK BB expression) demonstrate an increased protection of hepatocytes during periods of low oxygen stress (Miller et al., 1993) .
A decrease in CK BB activity is one of the biochemical markers of the CNS cell damage in age-related neurodegenerative diseases, including AD (Hensley et al., 1995; Aksenov et al., 1997; Aksenova et al., 1999) . The decrease of CK BB activity and content in the brain in AD correlates well with the hallmarks of neurodegeneration in severely affected regions (Hensley et al., 1995) . Damage of CK function may be an important part of a neurodegenerative pathway that leads to neuronal loss in the brain (Tomimoto et al., 1993) .
The reduced level of CK BB, observed in several neurodegenerative disorders, is not a result of decreased CK BB gene expression and correlates with the content of protein carbonyls. Posttranslational oxidative modification of the enzyme may contribute to the loss of CK BB activity in neurodegenerative disorders (Aksenov et al., 1997; Aksenova et al., 1999) . However, direct evidence for the presence of oxidatively modified CK in the brain with neurodegenerative pathology is lacking. This study was designed to investigate the content of protein carbonyls in CK BB in AD.
MATERIALS AND METHODS

Tissue
Specimens from the superior and middle temporal gyri (SMT) were obtained at autopsy from six AD patients (mean Ϯ SEM age, 80.4 Ϯ 2.7 years) and six age-matched control subjects (81.1 Ϯ 3.6 years). Mean Ϯ SEM postmortem interval was 3.3 Ϯ 0.97 h for AD patients and 3.9 Ϯ 0.5 h for control subjects. All AD patients had clinical diagnoses of probable AD using NINCDS-ADRDA Work Group Criteria (McKhann et al., 1984) . For histopathologic diagnoses, hematoxylin and eosin, modified Bielschowsky, and Gallyas stains were used along with 10D-5 and ␣-synuclein immunohistochemistry. All AD patients met accepted standard criteria for the histopathologic diagnosis of AD (National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria, 1997). Controls were individuals without a history of dementia, other neurological diseases, or systemic diseases affecting the brain. All control subjects were from the University of Kentucky normal volunteer control group, who underwent annual neuropsychological testing. Neuropathological evaluation of control brains revealed no significant gross alterations and only ageassociated microscopic changes.
Brain specimens for the study were removed rapidly at autopsy, immediately placed in liquid nitrogen, and stored at Ϫ70°C.
Brain tissue extract preparation
Brain samples were thawed, minced, and suspended in 10 mM HEPES buffer (pH 7.4) containing 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH 2 PO 4 , 0.6 mM MgSO 4 , and the proteinase inhibitors leupeptin (0.5 g/ml), pepstatin (0.7 g/ml), type IIS soybean trypsin inhibitor (0.5 g/ml), and phenylmethanesulfonyl fluoride (40 g/ml). Homogenates were centrifuged at 16,000 g for 10 min to remove debris. Protein concentration was determined by the Pierce bicinchoninic acid method (Sigma, St. Louis, MO, U.S.A.).
CK activity assay
CK activity was determined colorimetrically by using a commercial kit (Sigma). One unit of total CK activity was determined as the amount of the enzyme that converts 1 mol of creatine to CrP/min at 37°C, pH 9.0.
Separate detection of CK BB and ubiquitous mitochondrial CK (uMt CK) activities in AD and control brain extracts was performed using CK activity staining following the separation of CK isoforms by nondenaturing gel electrophoresis. One microliter of brain tissue extract (1 mg of total protein/ml) was applied to each lane of 1.0% agarose Corning Multitrac CK Isoenzyme Gel/8 and electrophoresed in CK isoenzyme buffer at 90 V for 20 min (CIBA, Corning Diagnostic Corp., Palo Alto, CA, U.S.A.). Each gel included AD and control samples and the CK BB activity standard [0.125 mU of pure CK BB (Sigma)]. The enzyme activity pattern was developed by layering the plates with CK reagent (Corning). The plates were incubated at 37°C for 20 min. CK isoenzymes were detected through the following reactions:
glucose-6-phosphate dehydrogenase 6-phosphogluconate ϩ NADH ͑fluorescent͒
The enzyme activity bands were visualized with ultraviolet light. Gels were photographed, and gel images were digitized and quantified by computer-assisted imaging using MCID/M4 software supplied by Imaging Research (St. Catharines, Ontario, Canada).
Derivatization of protein carbonyls
Derivatization with 2,4-dinitrophenylhydrazine (DNPH) was carried out according to the procedure of Levine et al. (1994) . Four volumes of 10 mM DNPH/2 M HCl were added to each sample. Samples were incubated with agitation for 30 min at room temperature, and proteins were precipitated by addition of ice-cold 100% trichloroacetic acid to the final concentration of 15%. Samples were incubated on ice for 10 min, and precipitates were centrifuged at 15,000 g for 10 min. The precipitated protein was washed with 1 ml of 1:1 (vol/vol) ethanol/ethyl acetate followed by centrifugation for 15 min at 15,000 g three times, and resolubilized in 0.6 ml of 8 M urea. Samples of DNPH-treated brain proteins from AD and control subjects were used for one-and two-dimensional (1D and 2D, respectively) immunoblotting analysis of protein carbonyls.
1D and 2D electrophoresis of AD and control brain extracts
1D sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (12%) was performed in minislabs (0.75 ϫ 60 ϫ 70 mm) according to the method of Laemmli (1970) . Duplicate SDS-PAGE was carried out at 20 mA per gel for ϳ1 h. Five micrograms of total protein from DNPH-treated or nontreated AD and control brain extracts was loaded per lane and electrophoresed in the presence of internal oxidized protein or CK BB standard. Aliquots of nontreated brain extracts were used to determine the content of immunoreactive CK BB for the calculation of specific CK BB activity in AD and control samples. One gel was stained with Coomassie Blue for verification of the amount of protein applied, and another was transferred to nitrocellulose membrane. 1D blots were used for the routine immunoblot analysis of oxidized proteins and/or CK BB.
2D PAGE was performed in a Multiphor II Electrophoresis system using 110-mm pH 3-10 (linear) Immobiline DryStrips and ExcelGel XL 12-14 gels (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.). Samples of brain proteins derivatized with DNPH were diluted to 2-4 mg/ml in 8 M urea and mixed 1:4 (vol/vol) with 2D PAGE sample buffer [8.7 M urea, 1.0% (wt/vol) dithiothreitol, 2.0% (vol/vol) Pharmalyte 3-10, 0.5% Triton X-100, and bromphenol blue].
For the first-dimension separation, a 50 -100-g aliquot of sample was applied to a rehydrated Immobiline DryStrip. Isoelectric focusing was carried out at 15°C in a Multiphor II electrophoresis unit in conjunction with an EPS 3500 power supply. Until the second-dimension separation, sets of strips containing electrofocused AD and control samples were kept at Ϫ70°C.
Before the second-dimension separation, Immobiline DryStrips were equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6 M urea, 1% (wt/vol) SDS, 30% (vol/vol) glycerol, and 0.5% dithiothreitol. Strips were then reequilibrated for 10 min in the same buffer containing 4.5% iodacetamide in place of dithiothreitol. Pairs of strips (AD and control) were placed on ExcelGel XL SDS 12-14 gels. After application of 8 l of prestained markers (Bio-Rad) and standard amounts of either protein carbonyls [DNPH-treated bovine serum albumin (DNP-BSA)] or CK BB, the electrophoresis was started. 2D electrophoresis conditions are shown in Table 1 .
Following electrophoresis, gels were removed from plastic backing and transferred to nitrocellulose membrane or stained with colloidal Coomassie Blue (Sigma). Staining of 2D gels with collodial Coomassie Blue was performed as recommended by the manufacturer. The BLOT-FastStain kit (Geno Technology, Maplewood, MO, U.S.A.) was used for the reversible staining of transferred proteins. Staining and destaining of membranes were performed according to the protocol provided by the manufacturer. 2D blots were used for immunodetection of oxidized proteins and/or CK BB.
Western blot analysis for immunoreactive CK BB and protein carbonyls
After transfer, membranes were blocked in 3% BSA in phosphate-buffered saline with 0.01% sodium azide and 0.2% Tween 20 (PBST) for 1 h at room temperature. After blocking, membranes were used for the immunodetection of oxidized proteins and CK BB protein.
To determine the level of immunoreactive CK BB, nitrocellulose membranes obtained after the transfer of 1D and 2D gels were incubated for 1 h at room temperature with polyclonal anti-human CK BB antibody (Burbaeva et al., 1992) . Primary antibody was diluted 1:1,000 in 0.3% BSA/PBST.
To determine the level of protein oxidation, 1D and 2D blots were incubated with rabbit anti-DNP antibody (Oncor, Gaithersburg, MD, U.S.A.) diluted 1:150 in 0.3% BSA/PBST. Membranes were incubated with the primary antibody for 1 h at room temperature.
After incubation with primary antibodies was complete, membranes were washed for 10 min in PBST three times.
Secondary antibody (anti-rabbit alkaline phosphatase-conjugated IgG; Sigma) was diluted 1:30,000 in 0.3% BSA/PBST and incubated with blots for 1 h at room temperature. Membranes were washed three times (10 min per wash) with PBST and developed using 5-bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium (BCIP/NBT) solution (SigmaFast tablets; Sigma).
Imaging analysis of nondenaturing agarose gels stained for CK BB activity and 1D and 2D western blots
Calibration of the intensity of the fluorescent CK BB activity staining in nondenaturing agarose gels to units of CK activity was performed using different dilutions of standard (0.01 U/l) CK BB solution (Fig. 1A) . AD and control samples were always electrophoresed in the presence of the internal standard as described above. CK BB activity patterns were digitized, CK activity units were calculated, and data were normalized to CK BB content determined by immunoblotting. The CK BB activity per microgram of immunoreactive CK BB protein was calculated for each AD and control subject. Calibration of anti-CK BB immunostaining to the amount of CK BB protein was performed using different dilutions of standard (0.1 g/l) solution of 99% pure human CK BB (Calbiochem, La Jolla, CA, U.S.A.) (Fig. 1B) . The standard amount of pure CK BB (10 ng for 1D) was included in SDS-PAGE when the CK BB level was determined on 1D or 2D western blots. CK BB-positive immunobands on 1D western blots and CK BB-positive spots on 2D western blots stained with anti-CK BB antibody were digitized and quantified by computer-assisted imaging using MCID/M4 (Imaging Research). CK BB was localized in 2D fingerprints and 2D Oxyblots by computer-assisted alignment (MCID/M4 software option) of images of 2D western blots stained for CK BB immunoreactivity with 2D blots reversibly stained for total protein and/or with 2D Oxyblots.
Protein carbonyl levels in CK BB were assessed by comparing the intensity of anti-DNP staining of CK BB spots with an internal standard (0.4 pmol of protein carbonyl in DNP-BSA band; Oncor). On Oxyblots developed with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium, the intensity of anti-DNP immunostaining was proportional to the amount of protein carbonyls within the range from 0 to 2.5 pmol on the gel (Aksenova et al., 1999) . The anti-DNP-positive CK BB spots in 2D Oxyblots were digitized and quantified, and data were normalized to immunoreactive CK BB content. The CK BB carbonyl/immunoreactive CK BB ratio was calculated for each AD and control subject.
Statistical analysis
Individual CK BB activity/immunoreactive CK BB and CK BB carbonyl/immunoreactive CK BB ratios calculated for AD subjects were compared with the ratios calculated for control subjects. Statistical comparisons were made using ANOVA followed by Dunnett's test for multiple comparisons. Significant differences were set at p Ͻ 0.05.
RESULTS
To demonstrate that a posttranslational modification of CK BB molecules contributes to the decrease of total CK activity in the AD brain, we determined specific CK BB activity per milligram of immunoreactive CK BB in the SMT cortex of AD and control subjects. When the results of imaging analysis of CK BB activity in AD and control SMT extracts were normalized to the enzyme content, AD CK BB exhibited 2.2-fold lower activity per milligram of CK BB protein than control CK BB ( p ϭ 0.0003; Fig. 2 ). In control SMT extracts, specific CK BB activity was 67.6 Ϯ 6.5 U/mg of CK BB protein; in AD SMT extracts, specific CK BB activity was 30.9 Ϯ 4.4 U/mg of CK BB protein. The decrease of CK BB activity per milligram of immunoreactive CK BB protein indicated the presence of inactive CK BB molecules in a fraction of water-soluble proteins in the AD SMT cortex.
Protein carbonyl content in AD subjects used in this study was two times higher than in controls (197 Ϯ 10% of control, p ϭ 0.0003), as determined by routine 1D western blot analysis for protein carbonyls. To determine if CK BB contains reactive carbonyl groups in AD or control brain extracts, we used high-resolution 2D electrophoresis of DNPH-treated brain proteins followed by anti-protein carbonyl immunostaining of 2D blots. Partial images of AD and control 2D Oxyblots are shown in Fig. 3 . On 2D fingerprints of DNPH-treated human brain protein extracts, immunostaining for CK BB revealed one to three closely located spots (43 kDa, pI 5.5-6.0). The pI and molecular mass of CK BB-positive spots in DNPH-treated samples were consistent with the results of other authors, who analyzed CK BB properties by isoelectric focusing or 2D electrophoresis (Barrantes et al., 1983; Mahadevan et al., 1984; Kanemitsu and Okigaki, 1994) . The intensity of protein staining of CK BB spots in AD brain extracts was lower than in controls, which is consistent with the results of 1D and 2D western blot analysis of CK BB content. However, no qualitative difference in the position of CK BB spots on AD and control 2D maps was observed.
FIG. 2. Decrease of specific CK BB activity in AD SMT extracts compared with age-matched controls. A:
A typical result of fluorescent activity staining of CK isoenzymes from AD and control SMT cortex separated by nondenaturing agarose electrophoresis. Arrow points to uMt CK. The first lane represents the activity of CK BB standard (125 U). The last lane represents the standard mixture of three CK isoenzymes-BB, MB, and MM. B: A partial image of a 1D western blot stained for CK BB immunoreactivity. This image includes three AD and control samples (5 g of total protein per lane, no DNPH treatment; same as shown in A) and CK BB standard (10 ng of pure CK BB). C: Decrease of specific CK BB activity in AD brain extracts. Data obtained from the immunoblotting analysis of CK BB content in AD (n ϭ 6) and control (n ϭ 6) brain extracts were used for calculation of specific CK BB activity. Individual CK BB activity/CK BB content ratios were averaged, and the results are mean Ϯ SEM (bars) values. *p Ͻ 0.0005.
As illustrated in Fig. 3 , CK BB was one of the anti-DNP-positive spots on 2D Oxyblots from AD and control brain samples. Although the content of CK BB was significantly decreased in AD, CK BB spots on 2D Oxyblots usually showed higher anti-DNP immunoreactivity in AD than in control samples (Figs. 2B and 4A and B) . When the amount of protein carbonyls in CK BB from AD and control samples was normalized to the subsequent amount of CK BB protein, specific levels of CK BB carbonyls were 3.4-fold higher in AD than in control SMT ( p ϭ 0.007; Fig. 4C ): In control SMT extracts, the content of protein carbonyls in CK BB was 98 Ϯ 10 fmol/g of CK BB protein; in AD SMT extracts, the content of protein carbonyls in CK BB was 330 Ϯ 80 fmol/g of CK BB protein.
CK BB contains sulfhydryl groups essential for its activity. To determine if the reversible oxidation of CK BB thiols contributed to CK activity decrease in the AD brain, control and AD brain extracts were pretreated with varying concentrations of ␤-mercaptoethanol, and CK activity was determined. Pretreatment of the AD samples with ␤-mercaptoethanol did not increase CK activity in AD brain extracts (data not shown), which suggests an S-S reducing agent does not reverse the inhibition of CK activity in the brain in AD.
DISCUSSION
In our previous studies (Aksenov et al., 1997; Aksenova et al., 1999) , we reported CK BB mRNA content does not change significantly in the AD brain. Nevertheless, CK activity (cytosolic plus mitochondrial CK) and CK BB content per milligram of total extracted protein are decreased in AD. Therefore, we suggested that a posttranslational modification may cause a decrease of CK activity in AD (Aksenov et al., 1997) . The decrease of CK BB activity per milligram of immunoreactive protein, which was observed in this study, indicates that inactive CK BB molecules are present in brain extracts of AD patients.
CKs are sensitive to oxidative damage (Park and Thomas, 1988; Thomas et al., 1994; Mekhfi et al., 1996; Konorev et al., 1998) and might be one of the targets for reactive oxygen species in the brain in AD (Aksenov et al., 1997) . This study demonstrates that CK BB in the AD brain extracts contains more protein carbonyls than in controls, which provides evidence for increased oxidation of CK BB in AD. Thus, posttranslational oxidative modification of CK BB, which correlates with the decrease of enzyme activity, occurs in the AD brain.
Our results showed that a 2.2-fold decrease of CK BB specific activity in the AD brain was accompanied by a 3.4-fold increase of CK BB protein carbonyl content. This indicates that protein carbonyl formation may account for the CK BB inactivation in AD.
Conversion of the amino acid side chains into carbonylcontaining derivatives causes activity loss in many enzymes (Fucci et al., 1983; Stadtman, 1990) . Introduction of carbonyl groups at lysine, arginine, proline, histidine, or threonine amino acid residues (Butterfield and Stadtman, 1997) may change the charge of a protein. However, if oxidative damage of a protein is limited to the modification of only a few amino acid residues, the "needle-point" changes that caused protein damage may be not notable. In our study, we did not observe significant alterations in 2D electrophoretic mobility of CK BB in AD brain extracts. As reported by Kanemitsu and Okigaki (1994) , hydrogen peroxide-induced oxidation of CK BB does not alter its isoelectric focusing pattern. Our preliminary experiments (not shown in this report) showed that 1D electrophoretic mobility of the iron/ hydrogen peroxide-treated CK BB does not change owing to the increased carbonyl content. Therefore, the absence of notable changes in electrophoretic properties of oxidized CK BB in AD brain extracts was not surprising. Rather, it suggests that inactivation of CK BB may not be a result of massive nonspecific oxidation of the protein. Loss of CK BB activity in AD may be caused by modification of a limited number of essential amino acid residues, as dem- onstrated for other oxidatively sensitive enzymes (Fucci et al., 1983; Levine, 1983) .
Based on our finding of the increased protein carbonyl content in CK BB in AD, several mechanisms of the enzyme inactivation and loss can be suggested. The recent study of David et al. (1998) demonstrated a correlation between reduced CK activity and decreased ATP binding to CK BB in the AD brain. The ATP-binding domain of CK BB contains essential arginine (Wood et al., 1998) , histidine (Forstner et al., 1997) , lysine (Nevinskii et al., 1983) , and cysteine (Sheikh et al., 1993) , amino acid residues that may be targeted by reactive oxygen species.
Oxidative inactivation of CK BB may involve the direct free radical-mediated oxidation of these amino acid residues in the ATP-binding site of CK BB to carbonyl-containing derivatives. The site-specific modification of arginine and/or lysine at the ATP-binding site of CK BB may result from the reaction of hydrogen peroxide with small amounts of transition metals, which can bind to histidines close to the active site. Micromolar levels of iron can significantly enhance oxidation of CK by hydrogen peroxide (Thomas et al., 1994) . We observed that iron/peroxide-induced inactivation of purified CK BB coincides with the increase of protein carbonyl content (authors' unpublished data).
Alternatively, interaction of reactive di-or polyaldehyde compounds, generated as a result of oxidative stress in the AD brain, with essential lysine, arginine, and/or cysteine residues may block the ATP binding to CK BB and cause introduction of carbonyl groups into CK BB protein. The possibility of chemical modification of the CK BB ATP-binding domain by different substances with reactive aldehyde groups was demonstrated in several studies (Nevinskii et al., 1983; Wood et al., 1998) . It is possible that products of lipid oxidation and glycoxidation, levels of which are increased in AD Seidl et al., 1997; Markesbery and Carney, 1999) , may cause oxidative damage of CK BB.
Results that demonstrate the affinity modification of CK by 2Ј,3Ј-dialdehyde derivatives of ADP and ATP (Nevinskii et al., 1983) and nucleotidylation of CK BB in vitro (David and Haley, 1999) suggest that increased carbonylation and inactivation of CK BB in AD may result from interaction of the enzyme with oxidatively damaged phosphonucleotides.
Carbonyl groups introduced into CK BB during its oxidative modification in vivo may further participate in various chemical reactions. Our results of carbonyl detection in CK BB are likely to reflect a dynamic process of oxidative inactivation of the enzyme in AD, which involves the formation of carbonyl-containing intermediates. In addition, data reported in this study do not rule out the possibility that free radical-induced modifications other than the formation of carbonyl groups may take part in oxidative inactivation of CK BB in the AD brain. The elevated production of peroxynitrate in the brain in AD (Good et al., 1996; ) may contribute to CK BB damage through nitration of tyrosines and oxidation of sulfhydryl groups in the enzyme (Leydier et al., 1997; Konorev et al., 1998) .
Direct oxidation of sulfhydryl groups in cysteines located in the active site of CK also may inactivate the enzyme. Different types of oxidants induce either reversible or irreversible modification of thiols in CK (Korge and Campbell, 1993; Thomas et al., 1994; Konorev et al., 1998) . The loss of CK activity that resulted from the transformation of sulfhydryl groups in cysteines into S-S bonds can be successfully reversed by sulfhydryl reagents, such as glutathione, dithiothreitol, or ␤-mercaptoethanol (Korge and Campbell, 1993) . Thiol oxidation in CK that was resistant to reversal with GSH was reported when CK was treated with xanthine/xanthine oxidase or peroxynitrite (Konorev et al., 1998) . In our study, we observed that the pretreatment of the AD SMT extracts with ␤-mercaptoethanol did not significantly increase CK activity, which suggests that if the oxidative inactivation of CK BB in AD involves the modification of cysteines, it has to be the irreversible oxidation of thiols.
Oxidative modification of CK BB aids in explaining the decrease of CK BB content in AD brain extracts. Oxidation can make proteins susceptible to proteolysis and induce protein fragmentation and cross-linking (Stadtman, 1993; Butterfield and Stadtman, 1997) . The loss of CK BB in the AD brain may be at least partly attributed to the degradation of CK BB molecules damaged by oxidation. Loss of CK BB immunoreactivity during cerebral ischemia in the hippocampal CA1 region of gerbils was reported by Tomimoto et al. (1993) . Oxidative modification can cause the abnormal partitioning of CK into brain pellet, which was reported in two studies (Klushnik et al., 1991; David et al., 1998) . Increased carbonylation of CK BB protein can promote cross-linking of the enzyme to membranes or insoluble abnormal neurofibrils, which accumulate in neurons in AD. Supportive to that is the presence of CK BB immunoreactivity in neurofibrillary tangles in AD (Burbaeva et al., 1992) . It seems likely that both degradation of oxidatively damaged CK BB and its cross-linking to components of insoluble brain material contribute to the decrease of CK BB content in brain extracts from AD patients.
Protein carbonyl formation is increased in severely affected regions of the AD brain and may be an early event in neurodegenerative process (C. D. Smith et al., 1991; Hensley et al., 1995; M. A. Smith et al., 1996 Butterfield and Stadtman, 1997; Aksenova et al., 1999) . Therefore, the identification of protein targets of oxidative damage in the AD brain is important. The present study represents the first identification of an individual protein with increased carbonyl content in the AD brain and provides evidence that oxidative posttranslational modification of CK BB plays a role in the loss of CK BB activity in AD.
